Across TCGA pan-cancer cohorts, RNA5SP427 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RNA5SP427 data layer.
The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNA5SP427 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNA5SP427 expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.
ACC, KIRC, and KICH are the cancer types where RNA5SP427 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.